AVITA MedicalRCEL +0.13%66 Quick Ratio is 0.38 as of Mar. 2026, which is 94% below its 10-year median of 6.85. GuruFocus rates RCEL with a GF Score™ of 66/100 and a GF Value™ of $10.78 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 854 Medical Devices & Instruments companies, AVITA Medical ranks worse than 93.68% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. AVITA Medical's quick ratio for the quarter that ended in Mar. 2026 was 0.38.
AVITA Medical has a quick ratio of 0.38. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for AVITA Medical's Quick Ratio or its related term are showing as below:
RCEL'
s Quick Ratio Range Over the Past 10 Years
Min: 0.38 Med: 6.85 Max: 17.25
Current: 0.38
During the past 13 years, AVITA Medical's highest Quick Ratio was 17.25. The lowest was 0.38. And the median was 6.85.
RCEL's Quick Ratio is ranked worse than 93.68% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs RCEL: 0.38
AVITA Medical (NAS:RCEL) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
AVITA Medical Quick Ratio Related Terms
AVITA Medical Quick Ratio Historical Data
* Premium members only.
The historical data trend for AVITA Medical's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, AVITA Medical's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVITA Medical Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Quick Ratio distribution charts can be found below:
* The bar in red indicates where AVITA Medical's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
AVITA Medical's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVITA Medical (RCEL) has a Quick Ratio of 0.38 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on AVITA Medical and its competitors. This is 94% below median its historical median of 6.85. Over the past decade, AVITA Medical's Quick Ratio has ranged from 0.38 to 17.25. According to the industry distribution chart, AVITA Medical ranks #800 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 93.7%.
Is AVITA Medical's Quick Ratio too high?
AVITA Medical's current Quick Ratio of 0.38 is 94% below median its 10-year median of 6.85. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 17.25. The Medical Devices & Instruments industry median Quick Ratio is 1.87. AVITA Medical's value of 0.38 is 79.6% below this industry median. Based on the distribution chart, AVITA Medical ranks #800 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, AVITA Medical has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AVITA Medical's Quick Ratio compare to NNOX and MXCT?
According to the Medical Devices & Instruments industry distribution chart, AVITA Medical ranks #800 out of 854 companies for Quick Ratio. This places AVITA Medical in the lower half of its industry. The industry median Quick Ratio is 1.87. AVITA Medical's value of 0.38 is 79.6% below this benchmark. Historically, AVITA Medical's own Quick Ratio has ranged from 0.38 to 17.25 over the past decade. While the company's 10-year median is 6.85 vs. the industry median of 1.87, AVITA Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AVITA Medical's current Quick Ratio of 0.38 is 79.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on AVITA Medical and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AVITA Medical's current Quick Ratio is 0.38, which is 94% below median its own 10-year median of 6.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVITA Medical stock overvalued right now?
Based on GuruFocus' analysis, AVITA Medical (RCEL) is currently considered Possible Value Trap. The stock's GF Value™ is $10.78, compared to a current price of $3.93 — trading 63.5% below its estimated fair value. The current Quick Ratio is 0.38, which is 94% below median its 10-year median of 6.85 and 79.6% below the Medical Devices & Instruments industry median of 1.87. AVITA Medical's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For AVITA Medical (RCEL), the current Quick Ratio is 0.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AVITA Medical (RCEL) Overvalued in 2026?
Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued.
The current stock price of $3.93 is trading 63.5% below its estimated GF Value™ of $10.78.
GuruFocus considers AVITA Medical to be Possible Value Trap.
Key valuation signals for RCEL:
Quick Ratio: 0.38 (94% below median its 10-year median of 6.85)
GF Value™: $10.78 vs. price of $3.93 (63.5% below fair value)
Industry Position: 79.6% below the Medical Devices & Instruments median (#800 of 854)
No single metric tells the full story. See the RCEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
66GF Score
Get the complete analysis for RCEL
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RCEL has been successfully added to your 
